ASTM: up 333% now on my spec Jan 2.5 calls. and up 20% in stock. learn options and you will significantly increase your revenue potential. i plan on penning a piece about buying biotech options. Tony Pelz's book is a good start, but a little outdated. He said a new edition is forthcoming UPDATE: picked up 5k in RPC. hearing news tomorrow morning on some data